新型免疫抑制剂在免疫性神经肌肉疾病中的应用
陈俊,卜碧涛
摘要(Abstract)：
关键词(KeyWords)： 自身免疫性疾病;神经肌肉疾病;免疫抑制剂
基金项目(Foundation):
作者(Author): 陈俊,卜碧涛
参考文献(References)：
- [1]KOVARIK JM,BURTIN P.Immunosuppressants in AdvancedClinical Development for Organ Transplantation and SelectedAutoimmune Diseases[J].Expert Opin Emerg Drugs(S1472-8214),2003,8(1):47-62.
- [2]CREE B.Emerging Monoclonal Antibody Therapies for Multi-ple Sclerosis[J].Neurologist(S1074-7931),2006,12(4):171-178.
- [3]PONSETI JM,AZEM J,FORT JM,et al.Long-term Resultsof Tacrolimus in Cyclosporine-and Prednisone-dependent Myas-thenia Gravis[J].Neurology(S0028-3878),2005,64(9):1641-1643.
- [4]PONSETI JM,AZEM J,FORT JM,et al.Experience withStarting Tacrolimus Postoperatively after Transsternal Extend-ed Thymectomy in Patients with Myasthenia Gravis[J].CurrMed Res Opin(S0300-7995),2006,22(5):885-895.
- [5]TADA M,SHIMOHATA T,TADA M,et al.Long-termTherapeutic Efficacy and Safety of Low-dose Tacrolimus(FK506)for Myasthenia Gravis[J].J Neurol Sci(S0022-510X),2006,247(1):17-20.
- [6]MITSUI T,KUNISHIGE M,ICHIMIYA M,et al.BeneficialEffect of Tacrolimus on Myasthenia Gravis with Thymoma[J].Neurologist(S1074-7931),2007,13(2):83-86.
- [7]KONISHI T,YOSHIYAMA Y,TAKAMORI M,et al.Clini-cal Study of FK506 in Patients with Myasthenia Gravis[J].Muscle Nerve(S0148-639X),2003,28(5):570-574.
- [8]KONISHI T,YOSHIYAMA Y,TAKAMORI M,et al.Long-term Treatment of Generalised Myasthenia Gravis withFK506(Tacrolimus)[J].J Neurol Neurosurg Psychiatry(S0022-3050),2005,76(3):448-450.
- [9]赵重波,朱雯华,卢家红.小剂量他克莫司治疗难治性全身型重症肌无力的初步研究[J].中国临床神经科学,2005,13(4):406-409.
- [10]MERIGGIOLI MN,CIAFALONI E,AL-HAYK KA,et al.Mycophenolate Mofetil for Myasthenia Gravis:an Analysis ofEfficacy,Safety and Tolerability[J].Neurology(S0028-3878),2003,61:1438-1440.
- [11]CIAFALONI E,MASSEY JM,TUCKER-LIPSCOMBE B,etal.Mycophenolate Mofetil for Myasthenia Gravis:An Open-la-bel Pilot Study[J].Neurology(S0028-3878),2001,56:97-99.
- [12]MERIGGIOLI MN,ROWIN J,RICHMAN JG,et al.Myco-phenolate Mofetil for Myasthenia Gravis:A Double-blind,Pla-cebocontrolled Pilot Study[J].Ann NY Acad Sci(S0077-8923),2003,998:494-499.
- [13]LEVIN N,MALI A,KARUSSIS D.Severe Skin Reaction Re-lated to Mycophenolate Mofetil for Myasthenia Gravis[J].ClinNeuropharmacol(S0362-5664),2005,28(3):152-153.
- [14]VERNINO S,SALOMAO DR,HABERMANN TM,et al.Primary CNS Lymphoma Complicating Treatment of Myasthe-nia Gravis with Mycophenolate Mofetil[J].Neurology(S0028-3878),2005,65(4):639-641.
- [15]PESCOVITZ MD.Rituximab,an Anti-cd20 Monoclonal Anti-body:History and Mecha Nism of Action[J].Am J Transplant(S1600-6135),2006,6(5 Pt 1):859-866.
- [16]TUZUN E,MERIGGIOLI MN,ROWIN J,et al.MyastheniaGravis Patients with Low Plasma IL-6 and IFN-gamma Benefitfrom Etanercept Treatment[J].J Autoimmun(S0896-8411),2005,24(3):261-268.
- [17]VERMERSCH P,WAUCQUIER N,MICHELIN E,et al.Combination of IFN Beta-1a(Avonex)and MycophenolateMofetil(Cellcept)in Multiple Sclerosis[J].Eur J Neurol(S1351-5101),2007,14(1):85-89.
- [18]KAPPOS L,ANTEL J,COMI G,et al.FTY720 D2201 StudyGroup.Oral Fingolimod(FTY720)for Relapsing MultipleSclerosis[J].N Engl J Med(S0028-4793),2006,355(11):1124-1140.
- [19]RIECKMANN P.Escalating Immunomodulatory Therapy ofMultiple Sclerosis:Update(September 2006)[J].Nervenarzt(S0028-2804),2006,77(12):1506-1518.
- [20]POLMAN CH,O'CONNOR PW,HAVRDOVA E,et al.San-drock the AFFIRM Investigators.A Randomized,Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclero-sis[J].N Engl J Med(S0028-4793),2006,354:899-910.
- [21]RUDICK RA,STUART WH,CALABRESI PA,et al.San-drock the Sentinel Investigators.Natalizumab Plus InterferonBeta-1a for Relapsing Multiple Sclerosis[J].N Engl J Med(S0028-4793),2006,354:911-923.
- [22]ODDIS CV,SCIURBA FC,ELMAGD KA,et al.Tacrolimusin Refractory Polymyositis with Interstitial Lung Disease[J].Lancet(S0099-5355),1999,353:1762-1763.
- [23]MAJITHIA V,HARISDANGKUL V.Mycophenolate Mofetil(Cell-Cept):An Alternative Therapy for Autoimmune Inflam-matory Myopathy[J].Rheumatology(S1462-0324),2005,44:386-389.
- [24]PISONI CN,CUADRADO MJ,KHAMASHTA MA,et al.Mycophenolate Mofetil Treatment in Resistant Myositis[J].Rheumatology(S1462-0324),2007,46(3):516-518.
- [25]LEVINE TD.Rituximab in the Treatment of Dermatomyosi-tis:An Open-label Pilot Study[J].Arthritis Rheum(S0004-3591),2005,52:601-607.
- [26]PESTRONK A,FLORENCE J,MILLER T,et al.Treatmentof IgM Antibody Associated Polyneuropathies Using Rituximab[J].J Neurol Neurosurg Psychiatry(S0022-3050),2003,74:485-489.
- [27]GORSON KC,NATARAJAN N,ROPPER AH,et al.Ritux-imab Treatment in Patients with IVIg-dependent Immune Poly-neuropathy:A Prospective Pilot Trial[J].Muscle Nerve(S0148-639X),2007,35(1):66-69.
- [28]CHIN RL,SHERMAN WH,SANDER HW,et al.Etaner-cept(Enbrel)Therapy for Chronic Inflammatory Demyelina-ting Polyneuropathy[J].J Neurol Sci(S0022-510X),2003,210:19-21.